Optimizing the design and functionality of the CLL Mind Map, an Innovative Digital Decision Aid with A Dynamic Graphical Interactive Interface
Larry Cripe, MD
Primary Investigator
Brief description of study
What is the purpose of this study?
Optimize the design and functionality of the CLL Mind Map based upon feedback of patients with CLL or related indolent non-Hodgkin s lymphomad their designated caregiver.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Chronic lymphocytic leukemia, CLL, Non-Hodgkin s lymphoma
-
Age: Between 18 Years - 100 Years
-
Gender: All